Scientists Seek Stem Cell Cure For Spinal Cord Injuries | WAMU 88.5 - American University Radio

WAMU 88.5 : Metro Connection

Filed Under:

Scientists Seek Stem Cell Cure For Spinal Cord Injuries

Play associated audio
Thomas Hazel, Ph.D, and Richard Garr pose in their neural stem cell laboratory, in Rockville, Md.
Thomas Hazel, Ph.D, and Richard Garr pose in their neural stem cell laboratory, in Rockville, Md.

Neuralstem, a Rockville-based biotech company, has just been approved by the FDA to begin implanting stem cells into people with spinal cord injuries. While there's a long scientific journey ahead, this trial could mean hope for paraplegic and quadriplegic patients all over the world.

The nervous system works, by sending electrical signals up and down the spinal cord. Degenerative diseases like Multiple Sclerosis, ALS, or Parkinsons impair the ability to send those signals. "There's a gap," says Richard Garr, co-founder and CEO of Neuralstem. He says there's something that's blocking signals from getting through.

Unlike our skin cells, the central nervous system doesn't repair itself when damaged. "You're born with a certain number of neurons, and that's the way it is." says Garr.

In 1998, Garr met Karl Johe, Ph.D. who had made a discovery while working at NIH. Around week 7 or 8, when the human embryo is the size of the tip of your thumb, there are cells in the brain area of the embryo that have all the information they need to become neurons. These are called 'neural stem cells.' Dr. Johe developed and patented techniques for extracting and multiplying these cells, then implanting them as 'replacement neurons.'

"We're actually putting in cells that are going to turn into neurons that are going to bridge the gap," he says. "We're creating new circuitry."

Dr. Thomas Hazel, the head of Research at Neuralstem, explains one of the most important aspects of neural stem cells is that they can easily replicate. The lab received a donated tissue from a legally aborted fetus about 10 years ago, and they've been using those cells ever since.

The surgery recently approved by the FDA is much like an earlier trial, done on ALS patients. The surgeon injects neural stem cells directly into the patient's spinal cord. Those stem cells grow into neurons, and if all goes according to plan, they help messages pass from the brain to muscles.

The ALS trial is waiting for phase 2 approval, but patients, on their own, are reporting some improvement. The spinal cord trial will take on eight patients who have experienced injury in the past 1 to 2 years in the thoracic spine, which is from the chest, down. Neuralstem will announce the partner hospitals in the coming months, and hope to start the surgeries in summer 2013.


[Music: "One More Chance" by The Notorious B.I.G. from DJ LRM - Instrumental World Vol. 32]

NPR

Searching For Buried Treasure In China, A Writer Discovers Himself

During the Sino-Japanese War, Huan Hsu's great-great-grandfather buried his vast porcelain collection to keep it safe. Hsu went to find it 70 years later, on a trip about more than missing china.
NPR

Cheez Whiz Helped Spread Processed Foods. Will It Be Squeezed Out?

Turns out, the history of Kraft's dull-orange cheese spread says a lot about the processed food industry — and where it might be headed as Kraft and Heinz merge.
NPR

Proposed Payday Industry Regulations Must Strike Delicate Balance

The federal government is moving to reign in the payday loan industry, which critics say traps consumers in a damaging cycle of debt. A look at the possible effects of proposed regulations.
NPR

App That Aims To Make Books 'Squeaky Clean' Draws Ire From Edited Writers

Clean Reader — an app designed to find, block and replace profanity in books — has drawn considerable criticism from authors. This week, makers of the app announced they would no longer sell e-books.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.